The International Urology Cancer Summit (IUCS) and OncoDaily have entered a strategic partnership aimed at expanding the international visibility of the Summit and bringing education, scientific discussion, and developments in urologic oncology to a broader global audience.
As part of the strategic partnership, OncoDaily will support the visibility of the International Urology Cancer Summit 2026, taking place on 3-4 September 2026 in Guildford, United Kingdom.
The partnership brings together IUCS’s commitment to independent education and scientific exchange in urologic cancers with OncoDaily’s global platform for oncology news, education, and professional engagement.
Bringing Urologic Oncology to a Global Audience
Through the strategic partnership, OncoDaily will support the International Urology Cancer Summit in extending the reach of its scientific and educational activities to the wider oncology community.
The collaboration will help connect IUCS discussions and developments with oncologists, urologists, researchers, healthcare professionals, organizations, and other members of the international cancer community.
By increasing the visibility of an international meeting dedicated specifically to urologic malignancies, the partnership will contribute to broader scientific exchange around the evolving management of patients with urologic cancers.
International Urology Cancer Summit 2026 Comes to Guildford
A central focus of the partnership will be the International Urology Cancer Summit 2026, which will take place on 3-4 September 2026 at the University of Surrey in Guildford, UK.
The International Urology Cancer Summit is a free and independent educational opportunity open to everyone involved in caring for patients with urologic cancers.
Through an interactive platform combining in-person participation, live streaming, on-demand presentations from internationally recognized experts, and follow-up content through a dedicated website, the Summit provides participants with opportunities to engage with current approaches to the management of urologic cancers.
The 2026 congress will be held at the Austin Pearce Building, University of Surrey, Stag Hill, Guildford.
International Expertise at the Heart of IUCS 2026
The 2026 Summit is chaired by Giuseppe Luigi Banna, MD, Consultant Medical Oncologist and Honorary Associate Professor at Portsmouth Hospitals University NHS Trust and the University of Portsmouth, UK, and Ravindran Kanesvaran, MD, Distinguished Professor at Duke-NUS Medical School and Chair of the Division of Medical Oncology at the National Cancer Centre Singapore.
The international faculty includes specialists from the United Kingdom, United States, Singapore, Turkey, Italy, Germany, India, Hong Kong, Romania, and Argentina, reflecting the global scope of the meeting.
Among the faculty are Neeraj Agarwal, Sumanta Kumar Pal, Alison Tree, Yüksel Ürün, Emre Yekedüz, Pasquale Rescigno, Simon Crabb, Param Mariappan, Jeremy Teoh, Vincenza Conteduca, Stefanie Zschäbitz, Vanita Noronha, Michele Maffezzoli, Maria Barbu, Petros Grivas, María Natalia Gandur Quiroga, Vadim S. Koshkin, Aruni Ghose, Daniele Raggi, Debora Mukherji, Sebastiano Buti, Darren Poon, and Syed A Hussain, alongside the Summit chairs and other experts.
The Scientific Committee includes Giuseppe Luigi Banna, María Natalia Gandur Quiroga, Ravindran Kanesvaran, Michele Maffezzoli, Akash Maniam, Pasquale Rescigno, Yüksel Ürün, Aruni Ghose, Sebastiano Buti, and Emre Yekedüz.
An Interactive Forum Opens the 2026 Summit
The 2026 programme will begin on Thursday, 3 September, with the 1st Innovation Forum, an interactive workshop dedicated to urological malignancies.
Taking place from 9:30 to 11:30, the Innovation Forum will be held as a satellite workshop and is not part of the accredited scientific programme.
Registration for the workshop is separate from registration for the main International Urology Cancer Summit.
The interactive format reflects the wider educational approach of IUCS, creating opportunities for participants to engage directly with experts and discussions surrounding contemporary urologic cancer management.
Advancing Education Across Urologic Cancers
IUCS provides a dedicated international platform for professionals involved in the care of patients with urologic malignancies to engage with current developments across the field.
By combining presentations from internationally renowned experts with interactive discussion, live access, and on-demand educational content, the Summit supports continued learning beyond the congress itself.
The meeting brings together professionals from different countries and clinical backgrounds around a shared focus: keeping pace with the state-of-the-art management of urologic cancers.
The International Urology Cancer Summit 2026 has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 8 Category 1 external CPD credits, available to in-person participants.
The event has also been determined as compliant with the MedTech Europe Code of Ethical Business Practice and the EFPIA Code of Practice.
About the International Urology Cancer Summit
The International Urology Cancer Summit is a free and independent educational initiative dedicated to professionals involved in caring for patients with urologic cancers.
Through its international faculty, interactive congress format, live streaming, on-demand presentations, and dedicated educational content, IUCS provides a platform for sharing knowledge and engaging with developments in the management of urologic malignancies.
The Summit brings together expertise from across countries and disciplines, creating opportunities for scientific discussion, professional exchange, and continued education in urologic oncology.
About OncoDaily
OncoDaily is a global oncology media platform dedicated to providing timely, accurate, and accessible information to healthcare professionals, researchers, patients, advocates, organizations, and other members of the international cancer community.
Its coverage includes clinical research, treatment developments, oncology conferences, regulatory updates, professional education, cancer advocacy, healthcare policy, and developments across the global oncology landscape.
Through its website, newsletters, social media platforms, video programming, interviews, specialized oncology communities, journals, magazines, and other editorial formats, OncoDaily connects scientific developments with professionals and communities working across cancer care.
The strategic partnership with the International Urology Cancer Summit reflects a shared commitment to strengthening oncology communication, supporting scientific exchange, and expanding access to educational developments in urologic cancer care.
Strengthening International Collaboration in Urologic Oncology
The partnership between IUCS and OncoDaily creates an additional channel for bringing discussions and developments from the International Urology Cancer Summit to the wider oncology community.
By combining IUCS’s international educational platform and expertise in urologic malignancies with OncoDaily’s global media reach, the collaboration will support broader dissemination of scientific discussions, educational initiatives, congress developments, and news surrounding the field.
The partnership also reflects a shared interest in strengthening connections between specialists working across countries and disciplines while increasing international engagement with developments shaping the care of patients with urologic cancers.
International Urology Cancer Summit 2026
The International Urology Cancer Summit 2026 will take place on 3-4 September 2026 in Guildford, United Kingdom.
Date: 3-4 September 2026
Location: Austin Pearce Building, University of Surrey, Stag Hill, Guildford GU2 7XH, UK
CPD: 8 Category 1 external CPD credits for in-person participants
The International Urology Cancer Summit invites professionals involved in the care of patients with urologic cancers to join the meeting in Guildford for two days of education, scientific exchange, and international discussion around contemporary urologic oncology.
Through the strategic partnership, OncoDaily will support the international visibility of IUCS 2026 and bring its scientific and educational developments to the global oncology community.